يعرض 61 - 80 نتائج من 17,725 نتيجة بحث عن '(((( 50 we decrease ) OR ( 5 nm decrease ))) OR ( 50 ((a decrease) OR (teer decrease)) ))', وقت الاستعلام: 0.71s تنقيح النتائج
  1. 61

    Table_1_Decreased Risk in the Pancreatic Cancer With History of Hay Fever: A Meta-Analysis.doc حسب Guannan Wang (2209297)

    منشور في 2020
    "…A history of hay fever was associated with a decreased risk of pancreatic cancer (OR, 0.57; 95% CI, 0.50–0.64, P < 0.00001) through fixed effect model.…"
  2. 62

    Datasheet1_Impact of lockdown on children with type-1 diabetes: returning to the community was associated with a decrease in HbA1c.pdf حسب Benjamin Morat (17677977)

    منشور في 2023
    "…No significant difference was observed between medians of HbA1c_mean and HbA1c_after values (8.37% [7.88; 9.32%] vs. 8.50% [7.70; 9.50%], respectively; p = 0.391). …"
  3. 63

    Datasheet2_Impact of lockdown on children with type-1 diabetes: returning to the community was associated with a decrease in HbA1c.pdf حسب Benjamin Morat (17677977)

    منشور في 2023
    "…No significant difference was observed between medians of HbA1c_mean and HbA1c_after values (8.37% [7.88; 9.32%] vs. 8.50% [7.70; 9.50%], respectively; p = 0.391). …"
  4. 64
  5. 65

    Fluorescent intensity at 520 nm (RNase A/B) and 556 nm (DNase I) versus time for nucleases in DI water lysed with Lyse-It at 30% and 50% power for varying time. حسب Tonya M. Santaus (5559077)

    منشور في 2019
    "…<b>(A)</b> 20 pM RNase A <b>(B)</b> 46 pM RNase B, <b>(C)</b> 10.5 nM DNase I. As microwave power and time increase, nuclease activity decreases.…"
  6. 66

    Primers used in this study. حسب Hadi Alizadeh (20854757)

    منشور في 2025
    الموضوعات:
  7. 67

    S1 Dataset - حسب Nelmo Jordão Manjate (16324619)

    منشور في 2023
    "…This study aimed to estimate the cost of SARS-CoV-2 diagnosis of symptomatic suspected patients by reverse transcription polymerase chain reaction (RT-PCR) and antigen rapid diagnostic tests (Ag-RDT) in Mozambique. We conducted a retrospective cost analysis from the provider’s perspective using a bottom-up, micro-costing approach, and compared the direct costs of two nasopharyngeal Ag-RDTs (Panbio and Standard Q) against the costs of three nasal Ag-RDTs (Panbio, COVIOS and LumiraDx), and RT-PCR. …"
  8. 68

    Design and Synthesis of Novel sEH Inhibitors for the Treatment of Inflammatory Bowel Disease حسب Huashen Xu (13987046)

    منشور في 2025
    "…Especially, lead compounds <b>A1</b> and <b>A9</b> showed potent inhibitory activities against sEH (<b>A1</b> and <b>A9</b>; hsEH IC<sub>50</sub> = 0.1 nM, msEH IC<sub>50</sub> = 0.1 nM). …"
  9. 69

    Design and Synthesis of Novel sEH Inhibitors for the Treatment of Inflammatory Bowel Disease حسب Huashen Xu (13987046)

    منشور في 2025
    "…Especially, lead compounds <b>A1</b> and <b>A9</b> showed potent inhibitory activities against sEH (<b>A1</b> and <b>A9</b>; hsEH IC<sub>50</sub> = 0.1 nM, msEH IC<sub>50</sub> = 0.1 nM). …"
  10. 70

    Design and Synthesis of Novel sEH Inhibitors for the Treatment of Inflammatory Bowel Disease حسب Huashen Xu (13987046)

    منشور في 2025
    "…Especially, lead compounds <b>A1</b> and <b>A9</b> showed potent inhibitory activities against sEH (<b>A1</b> and <b>A9</b>; hsEH IC<sub>50</sub> = 0.1 nM, msEH IC<sub>50</sub> = 0.1 nM). …"
  11. 71

    Design and Synthesis of Novel sEH Inhibitors for the Treatment of Inflammatory Bowel Disease حسب Huashen Xu (13987046)

    منشور في 2025
    "…Especially, lead compounds <b>A1</b> and <b>A9</b> showed potent inhibitory activities against sEH (<b>A1</b> and <b>A9</b>; hsEH IC<sub>50</sub> = 0.1 nM, msEH IC<sub>50</sub> = 0.1 nM). …"
  12. 72

    Advancing the science of NOWS research. حسب Sarah E. Maylott (14560785)

    منشور في 2024
    "…It is not known which infants will develop NOWS, therefore, the current hospital standard-of-care dictates a 96-hour observational hold. Understanding which infants will develop NOWS soon after birth could reduce hospital stays for infants who do not develop NOWS and decrease burdens on hospitals and clinicians. …"
  13. 73

    Protocol measures. حسب Sarah E. Maylott (14560785)

    منشور في 2024
    "…It is not known which infants will develop NOWS, therefore, the current hospital standard-of-care dictates a 96-hour observational hold. Understanding which infants will develop NOWS soon after birth could reduce hospital stays for infants who do not develop NOWS and decrease burdens on hospitals and clinicians. …"
  14. 74

    Cry variables. حسب Sarah E. Maylott (14560785)

    منشور في 2024
    "…It is not known which infants will develop NOWS, therefore, the current hospital standard-of-care dictates a 96-hour observational hold. Understanding which infants will develop NOWS soon after birth could reduce hospital stays for infants who do not develop NOWS and decrease burdens on hospitals and clinicians. …"
  15. 75

    Phosphorylation as an Effective Tool to Improve Stability and Reduce Toxicity of Antimicrobial Peptides حسب Zufang Ba (11036420)

    منشور في 2024
    "…Phosphorylation can reduce toxicity and improve the stability of AMPs. Based on these, we designed a series of peptides and their corresponding phosphorylated forms. …"
  16. 76

    Influence of Interfacial Gas Enrichment on Controlled Coalescence of Oil Droplets in Water in Microfluidics حسب Jianlong Wang (438075)

    منشور في 2019
    "…The thickness of the IGE layer decreases from 5.5 to 4.9 nm when the amount of dissolved gas decreases from 7.89 to 4.59 mg/L. …"
  17. 77
  18. 78
  19. 79

    Addressing a Trapped High-Energy Water: Design and Synthesis of Highly Potent Pyrimidoindole-Based Glycogen Synthase Kinase-3β Inhibitors حسب Stanislav Andreev (11067165)

    منشور في 2021
    "…Here, by addressing a high-energy water, we improved the IC<sub>50</sub> value of our co-crystallized glycogen synthase kinase-3β (GSK-3β) inhibitor by nearly two orders of magnitude. …"
  20. 80

    Addressing a Trapped High-Energy Water: Design and Synthesis of Highly Potent Pyrimidoindole-Based Glycogen Synthase Kinase-3β Inhibitors حسب Stanislav Andreev (11067165)

    منشور في 2021
    "…Here, by addressing a high-energy water, we improved the IC<sub>50</sub> value of our co-crystallized glycogen synthase kinase-3β (GSK-3β) inhibitor by nearly two orders of magnitude. …"